【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 11
2.1 What Is This Report About? 11
3 Definitions of Markets/Categories Covered 12
3.1 Wound Care Management 12
3.1.1 Advanced Wound Management 12
3.1.2 Traditional Wound Management 12
3.1.3 Wound Closure Devices 12
4 Company Snapshot 13
4.1 Key Facts 13
4.2 Company Overview 13
4.3 Financial Performance 13
4.4 SWOT Snapshot 13
4.5 Business Overview 14
4.6 Major Products and Services 15
4.6.1 Overview 15
5 History 16
6 SWOT Analysis 21
6.1 Overview 21
6.2 Derma Sciences, Inc. Strengths 21
6.2.1 Broad Product Portfolio 21
6.2.2 Strong Manufacturing Capabilities 22
6.2.3 Strong Liquidity Position 22
6.3 Derma Sciences, Inc. Weaknesses 23
6.3.1 Weak Bottom Line 23
6.3.2 Over-dependence on the US Market 23
6.4 Derma Sciences, Inc. Opportunities 23
6.4.1 Acquisition of MedEfficiency 23
6.4.2 Aging Population 23
6.4.3 Promising Pipeline Products 24
6.5 Derma Sciences, Inc. Threats 24
6.5.1 Stringent Government Regulations 24
6.5.2 Competitive Landscape 24
6.5.3 Rapid Technological Changes 24
7 Competitors 25
8 Competitive Landscape 26
8.1 Wound Care Management (Advanced Wound Management), Global, Market Share (%), 2011 26
8.2 Derma Sciences, Inc., Wound Care Management (Advanced Wound Management), by Region, Market Share (2011) 28
8.3 Derma Sciences, Inc., Wound Care Management (Advanced Wound Management), by Country, Market Share (2011) 29
8.4 Wound Care Management (Traditional Wound Management), Global, Market Share (%), 2011 30
8.5 Derma Sciences, Inc., Wound Care Management (Traditional Wound Management), by Region, Market Share (2011) 32
8.6 Derma Sciences, Inc., Wound Care Management (Traditional Wound Management), by Country, Market Share (2011) 33
8.7 Wound Care Management (Wound Closure Devices), Global, Market Share (%), 2011 34
8.8 Derma Sciences, Inc., Wound Care Management (Wound Closure Devices), by Region, Market Share (2011) 36
8.9 Derma Sciences, Inc., Wound Care Management (Wound Closure Devices), by Country, Market Share (2011) 36
8.10 Derma Sciences, Inc., Wound Care Management, Global, Category Revenue Share (2011) 37
8.11 Derma Sciences, Inc., Europe, Category Revenue Share (2011) 39
8.11.1 Derma Sciences, Inc., United Kingdom, Category Revenue Share (2011) 41
8.12 Derma Sciences, Inc., North America, Category Revenue Share (2011) 43
8.12.1 Derma Sciences, Inc., Canada, Category Revenue Share (2011) 45
8.12.2 Derma Sciences, Inc., United States, Category Revenue Share (2011) 47
8.13 Derma Sciences, Inc., South and Central America, Category Revenue Share (2011) 49
8.13.1 Derma Sciences, Inc., Brazil, Category Revenue Share (2011) 51
8.13.2 Derma Sciences, Inc., Other South and Central America, Category Revenue Share (2011) 51
9 Key Employees 53
10 Key Employee Biographies 54
11 Company Statement 55
12 Locations And Subsidiaries 60
12.1 Head Office 60
12.2 Other Locations & Subsidiaries 60
13 Financial Deals Landscape 61
13.1 Derma Sciences, Inc., Deals Volume Summary, 2007 to 2012 61
14 Derma Sciences, Inc. Detailed Deal Summary 63
14.1 Partnerships 63
14.1.1 Derma Sciences Enters Into Licensing Agreement With Quick-Med Technologies For NIMBUS 63
14.1.2 Comvita New Zealand Enters Into An Agreement With Derma Sciences 65
14.1.3 Derma Sciences Enters Into Licensing Agreement With C-Boot 66
14.1.4 Derma Sciences Signs Licensing Agreement With Quick-Med Technologies 67
14.1.5 Derma Sciences Enters Into Distribution Agreement With Medline Industries 68
14.1.6 Derma Sciences Signs An Agreement With MedEfficiency 69
14.1.7 Derma Sciences Signs An Agreement With Novation 70
14.2 Equity Offering 71
14.2.1 Derma Sciences Completes Public Offering Of Shares For $36 Million 71
14.2.2 Derma Sciences Completes Private Placement Of Common Stock For $20 Million 73
14.2.3 Derma Sciences Completes Private Placement For $29 Million 75
14.2.4 Derma Sciences Completes Public Offering Of Common Stock For $5.6 Million 77
14.2.5 Derma Sciences Completes Private Placement Of $6.1 Million 79
14.2.6 Derma Sciences Completes Private Placement Of $6 Million 80
14.3 Acquisition 82
14.3.1 Derma Sciences Acquires MedEfficiency, Wound Care Management Company, For $14.5 Million 82
15 Recent Developments 84
15.1 Strategy And Business Planning 84
15.1.1 May 12, 2010: Derma Sciences Establishes New International Subsidiary In UK 84
15.2 Financial Announcements 84
15.2.1 Nov 12, 2012: Derma Sciences Reports Revenue Of $19.6m In Q3 2012 84
15.2.2 Aug 13, 2012: Derma Sciences Reports Revenue Of $17.6m In Q2 2012 85
15.2.3 May 15, 2012: Derma Sciences Reports Net Sales Of $15.3m In Q1 2012 85
15.2.4 Mar 29, 2012: Derma Sciences Reports Net Sales Of $16.5m In Q4 2011 86
15.2.5 Nov 11, 2011: Derma Sciences Reports Net Sales Of $15.8m In Q3 2011 86
15.2.6 Aug 16, 2011: Derma Sciences Reports Net Sales Of $15.9m In Q2 2011 87
15.2.7 May 11, 2011: Derma Sciences Reports Net Sales Of $14.4m In Q1 2011 88
15.2.8 Mar 30, 2011: Derma Sciences Reports Net Sales Of $56.5m In 2010 89
15.2.9 Nov 12, 2010: Derma Sciences Reports Net Sales Of $15.1 Million For Q3 2010 90
15.2.10 Aug 13, 2010: Derma Sciences Reports Net Sales Of $13.23 Million In Q2 2010 91
15.2.11 May 13, 2010: Derma Sciences Reports Net Sales Of $12.8 Million In Q1 2010 92
15.2.12 Apr 01, 2010: Derma Sciences Reports Net Sales Of $48.5 Million In 2009 93
15.2.13 Nov 16, 2009: Derma Sciences Reports Net Sales Of $12.9 Million In Q3 2009 94
15.2.14 Aug 17, 2009: Derma Sciences Reports Net Sales Of $11.6 Million In Q2 2009 95
15.2.15 May 18, 2009: Derma Sciences Posts Net Sales Of $10.4 Million In Q1 2009 96
15.2.16 Apr 01, 2009: Derma Sciences Posts Net Loss Of $3.96 Million For 2008 97
15.2.17 Nov 17, 2008: Derma Sciences Reports 3Q 2008 Results 98
15.2.18 Aug 14, 2008: Derma Sciences Reports 2Q 2008 Results 99
15.2.19 May 15, 2008: Derma Sciences Reports Q1 2008 Results 100
15.2.20 Apr 01, 2008: Derma Sciences Reports Q4 2007 Results 101
15.2.21 Mar 24, 2008: Derma Sciences To Declare Q4 2007 Results 101
15.2.22 Nov 13, 2007: Derma Sciences Reports Q3 2007 Results 102
15.2.23 May 16, 2007: Derma Sciences Declares Q1 2007 Results 103
15.2.24 Apr 02, 2007: Derma Sciences Reports Q4 2006 Results 103
15.2.25 Nov 14, 2006: Derma Sciences Reports Q3 2006 Results 104
15.2.26 Aug 15, 2006: Derma Sciences Reports Q2 2006 Results 105
15.3 Research And Development 106
15.3.1 Apr 18, 2011: Derma Sciences MEDIHONEY And XTRASORB Posters And Expert Presentations Featured At SAWC 2011 106
15.4 Corporate Communications 107
15.4.1 May 12, 2010: Derma Sciences Appoints Maeve Kelly As Managing Director, EMEA 107
15.4.2 Feb 10, 2010: Derma Sciences To List Its Common Stock On NASDAQ 107
15.4.3 Feb 09, 2010: Derma Sciences To List Its Common Stock On NASDAQ 107
15.4.4 May 05, 2009: Derma Sciences Reports Voluntary Delisting From Defunct Boston Stock Exchange 108
15.4.5 Jan 18, 2008: Derma Sciences Increases Direct Sales Force For Advanced Wound Care 108
15.5 Government and Public Interest 109
15.5.1 Nov 04, 2011: Derma Sciences To Present At Lazard Capital Markets 8th Annual Healthcare Conference 109
15.5.2 Sep 26, 2011: Derma Sciences To Present At Jefferies 2011 Global Healthcare Conference 109
15.5.3 Nov 05, 2010: Rodman Announces Panel Discussion On Wound Care 109
15.6 Product News 110
15.6.1 Sep 20, 2012: Pilot Study In Patients With Head And Neck Cancer Finds That Derma Sciences’ Medihoney Reduces Hospital Stays In UK 110
15.6.2 Sep 06, 2012: Derma Sciences Launches Medihoney HCS In US 111
15.6.3 Jul 10, 2012: Derma Sciences Receives CE Mark For Medihoney HCS 111
15.6.4 Aug 08, 2011: Derma Sciences Achieves Key MEDIHONEY Sales Milestone 112
15.6.5 Aug 01, 2011: Derma Sciences Receives FDA Clearance For MEDIHONEY Hydrogel 112
15.6.6 Feb 28, 2011: Derma Sciences Receives FDA Clearance For MEDIHONEY Gel 113
15.6.7 Jul 09, 2010: Derma Sciences Submits 510(k) Application For MEDIHONEY Gel 113
15.6.8 Jun 22, 2010: Derma Sciences Announces Issuance Of Second US Patent To MEDIHONEY Alginate Dressing 113
15.6.9 Jun 07, 2010: Derma Sciences Receives CE Mark For ALGICELL Ag Wound Dressings 114
15.6.10 May 04, 2010: Derma Sciences Launches XTRASORB Foam Wound Dressing 114
15.6.11 Apr 20, 2010: Two Posters Featuring Derma Sciences’ MEDIHONEY Wins Top Honors At American Professional Wound Care Association’s 10th Annual Conference 115
15.6.12 Apr 06, 2010: Derma Sciences To Feature MEDIHONEY At American Professional Wound Care Association’s Annual Conference 115
15.6.13 Oct 21, 2009: Derma Sciences To Present Clinical Case Series Of MEDIHONEY At Upcoming Clinical Symposium On Advances In Skin And Wound Care 116
15.6.14 Feb 13, 2009: In Case Studies MEDIHONEY Dressings Proves To Be Effective For Non-Healing Venous Leg Ulcers 116
15.6.15 Oct 21, 2008: Derma Sciences Announces Commercial Launch Of XTRASORB 117
15.6.16 Sep 15, 2008: Derma Sciences Inc’s MEDIHONEY Proven To Speed Healing In Stalled Leg Ulcers 117
15.6.17 Sep 03, 2008: Derma Sciences Announces Launch Plan For MOBILITY1 Intermittent Compression Therapy Device 117
15.6.18 Jul 28, 2008: Derma Sciences Signs Innovative Technology Agreement With Novation For MEDIHONEY Wound & Burn Dressings 118
15.6.19 Jun 26, 2008: Derma Sciences Launches Honeycolloid 118
15.6.20 Jun 26, 2008: Derma Sciences Launches New MEDIHONEY Formulations : Active Leptospermum Honey 119
15.6.21 Jun 24, 2008: Derma Sciences Receives FDA Clearance To Sell MEDIHONEY Over The Counter 119
15.6.22 Jun 18, 2008: Derma Sciences MEDIHONEY Helps To Save Patient’s Limb 120
15.6.23 Apr 23, 2008: Derma Sciences Announces Agreement With MedAssets For MEDIHONEY Wound & Burn Dressings 120
15.6.24 Apr 08, 2008: New Study Shows The Use Of MEDIHONEY Wound & Burn Dressing Is Associated With Reduction In Wound Size 120
15.6.25 Mar 25, 2008: Derma Sciences’ MEDIHONEY Profiled In Several Television News Health Reports 121
15.6.26 Mar 20, 2008: Derma Sciences Announces Clinical Poster On Use Of MEDIHONEY Wound & Burn Dressings Wins First Place Award At APWCA 122
15.6.27 Mar 06, 2008: Derma Sciences Announces Numerous Clinical Presentations On MEDIHONEY Wound & Burn Dressings At Upcoming SAWC Conference 123
15.6.28 Nov 15, 2007: Derma Sciences Receives Second FDA 510K Clearance And Adds To Their MEDIHONEY Wound & Burn Dressings With Active Leptospermum Honey 123
15.7 Product Approvals 124
15.7.1 Aug 01, 2011: Derma Sciences Receives FDA Clearance For MEDIHONEY Hydrogel 124
15.7.2 Jun 07, 2010: Derma Sciences Receives CE Mark For ALGICELL Ag Wound Dressings 124
15.7.3 Jun 24, 2008: Derma Sciences Receives FDA Clearance To Sell MEDIHONEY Over The Counter 125
15.7.4 Nov 15, 2007: Derma Sciences Receives Second FDA 510K Clearance And Adds To Their MEDIHONEY Wound & Burn Dressings With Active Leptospermum Honey 125
15.8 Clinical Trials 126
15.8.1 Feb 13, 2009: In Case Studies MEDIHONEY Dressings Proves To Be Effective For Non-Healing Venous Leg Ulcers 126
15.8.2 Sep 15, 2008: Derma Sciences Inc’s MEDIHONEY Proven To Speed Healing In Stalled Leg Ulcers 126
15.8.3 Jun 18, 2008: Derma Sciences MEDIHONEY Helps To Save Patient’s Limb 126
15.8.4 Apr 08, 2008: New Study Shows The Use Of MEDIHONEY Wound & Burn Dressing Is Associated With Reduction In Wound Size 127
15.9 Other Significant Developments 128
15.9.1 Sep 02, 2010: Derma Sciences XTRASORB Product Line Receive Federal Reimbursement Codes 128
15.9.2 Feb 23, 2010: Derma Sciences Extends Contract Term With Quick-Med 128
15.9.3 May 06, 2009: Derma Sciences Signs Private Label Contract To Supply Label Adhesive Bandages 129
15.9.4 Jul 28, 2008: Derma Sciences Signs Two Year Distribution Agreement With Novation For MEDIHONEY Wound & Burn Dressings 130
15.9.5 Apr 23, 2008: Derma Sciences Signs Three Year Supply Agreement With MedAssets For MEDIHONEY Wound & Burn Dressings 130
15.9.6 Jan 18, 2008: Derma Sciences Increases Direct Sales Force For Advanced Wound Care 131
15.9.7 Apr 02, 2007: QMTI Signs License Agreement With DSI 131
16 Appendix 132
16.1 Research Methodology 133
16.2 Secondary Research 133
16.3 Primary Research 133
16.4 Models 134
16.5 Forecasts 134
16.6 Expert Panels 134
16.7 GlobalData Consulting 134
16.8 Currency Conversion 135
16.9 Contact Us 136
16.10 Disclaimer 136
【レポート販売概要】
■ タイトル：Derma Sciences, Inc.：市場シェア分析■ 英文：Derma Sciences, Inc. Market Share Analysis
■ 発行日：2013年2月28日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160490
■ 調査対象地域：グローバル
- 世界主要国におけるレジオネラ検査市場2015The report presents a detailed analysis of the Legionella diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Legionella definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Co …
- 世界のキャリアイーサネット機器市場動向（2012-2016）TechNavio's analysts forecast the Global Carrier Ethernet Equipment market to grow at a CAGR of 6.99 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to reduce the total expenditure of service providers. The Global Carrier Ethernet Equipment market has also been witnessing the increasing demand for EADs. However, the interoperability issues c …
- 風力発電産業向けナセル搭載LIDARシステムの世界市場2017-2021About Nacelle Mounted LIDAR Systems Market for Wind IndustryNacelle LIDAR is used to measure the wind speed and the direction of the wind directly ahead of the turbine. Although it is installed on the nacelle, it can measure the wind without being affected by the turbine. The main purpose of the installing nacelle LIDAR is for integration for turbine control and as a retrofit for independently mea …
- レーザー・フィルタ保護（安全ゴーグル）の世界市場2016-2020About Laser Filter Laser filter protection or laser safety goggles are used to protect workers from exposure to lasers during manufacturing, laboratory processes, and others. Depending on the type of laser, different types of laser filter protection are used. Technavio’s analysts forecast the global laser filter protection market to grow at a CAGR of 5.50% during the period 2016-2020. [Covered in …
- 世界の吸収冷凍器市場2015The Global Absorption Chillers Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Absorption Chillers industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Absorption Chillers market analysis is provided for the international markets including developmen …
- 末梢神経障害(感覚性ニューロパチー)(Peripheral Neuropathy)の治療薬パイプライン動向（2015年上半期版）Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015’, provides an overview of the Peripheral Neuropathy (Sensory Neuropathy)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy), com …
- ペラルゴン酸の世界市場2015Pelargonic Acid (CAS 112-05-0) Market Research Report 2015 aims at providing comprehensive data on Pelargonic Acid market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Pelargonic Acid description, covers its application areas, manufacturing methods, patterns. It captures Pelargonic Acid market trends, pays close attention to Pelargonic Acid manufactu …
- 自動車サンルーフの世界市場2017-2021About Automotive SunroofAutomotive sunroofs may be fixed, vent, or sliding roofs that allow light and fresh air to enter the vehicle and also protects against the sun and wind. They can be operated manually or can be driven by motors. They are available in different sizes, shapes, and styles. Technavio’s analysts forecast the global automotive sunroof market to grow at a CAGR of 11.22% during the …
- グローバル食品/飲料/ケア製品市場におけるイノベーション戦略：新手法、事例分析Summary “Innovation Strategies: New techniques and best practice case studies in Food, Drink, and Personal Care” provides detailed insight into new opportunities in new product development, cross-category promotion, and marketing campaigns in both developing and developed countries. The evolution of consumption habits across the world means both retailers and manufacturers need a renewed understan …
- 世界のグリッド最適化ソリューション市場動向（2012-2016）TechNavio's analysts forecast the Global Grid Optimization Solutions market to grow at a CAGR of 40.32 percent over the period 2012-2016. One of the key factors contributing to this market growth is the emergence of smart grids. The Global Grid Optimization Solutions market has also been witnessing the exposure to cyber-attacks. However, the exposure to cyber-attacks could pose a challenge to the …
- 世界の海洋掘削サービス市場（市場予測、機会、トレンド2013-2017）The global drilling industry has been undergoing a slowdown in progress since the global economic crisis along with the financial crisis affecting the European countries. The high prices of crude oil and natural gas has been driving the drilling industry in recent years, combined with the ever growing demand for crude oil and natural gas. Offshore drilling is the fastest growing sector for the glo …
- 豚の健康管理の世界市場Swine Health The global swine health market is expected to benefit from the increasing incidence of disease through swine. The disease is associated with an increased cost burden in many developed and developing economies. As the demand for livestock is increasing, end-users are increasingly opting for antibiotics and vaccines. Also, vendors are extensively conducting R&D activities to develop nov …
- コールドチェーンの世界市場：低温貯蔵施設、冷蔵輸送The cold chain market applicable to perishable foods is projected to grow at a CAGR of 15.6% from 2014 to 2019. The two main infrastructure types of cold chain studied in this report are refrigerated storage and refrigerated transport. The refrigerated transport market in the cold chain is projected to grow at a considerable rate in Europe and North America, due to increase in the trade of perisha …
- 世界の農作物保護用化学薬品市場：除草剤、殺菌剤、殺虫剤The global crop protection chemicals market is segmented into all major regions and further, their key countries. In terms of regions, the report is segmented into North America, Europe, Asia-Pacific, Latin America, and Rest of the World (RoW). Asia-Pacific and North America are the top two consumers of crop protection chemicals, accounting together for nearly 50% of the total market share. Asia-P …
- アゾキシストロビンの世界市場2016-2020About the Azoxystrobin Market Fungicides are chemicals that are formulated to kill fungi. Triazoles, strobilurins, dithiocarbamates, phthalimides, and benzimidazoles are commonly used fungicides. Azoxystrobin is a systemic fungicide that belongs to the class of the strobilurin fungicides. Azoxystrobin helps in protecting crops against prevalent fungal diseases including Septoria leaf blotch, rye l …
